Erector spinae plane block for pain after laparoscopic abdominal surgery
Efficacy of Erector Spinae Plane Block on Postoperative Analgesia in Patients Undergoing Laparoscopic Abdominal Surgeries
This will test whether giving an erector spinae plane block reduces pain and 24-hour opioid use for adults having laparoscopic abdominal surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Assiut University Academic / other |
| Locations | 1 site (Asyut) |
| Trial ID | NCT07272577 on ClinicalTrials.gov |
What this trial studies
This interventional study delivers an erector spinae plane block (ESPB) to adult patients undergoing laparoscopic abdominal procedures under general anesthesia and measures postoperative analgesia. Pain scores and opioid consumption over the first 24 hours after surgery will be recorded to compare analgesic effectiveness. The protocol enrolls ASA I–II adults with BMI 20–30 kg/m2 and excludes patients with bleeding disorders, local sepsis, chronic pain, opioid dependence, or other contraindications to regional anesthesia. Outcomes will be used to determine whether ESPB provides improved postoperative pain control in this surgical population.
Who should consider this trial
Good fit: Adults aged 18 or older with ASA physical status I–II and BMI 20–30 kg/m2 who are scheduled for laparoscopic abdominal surgery under general anesthesia would be eligible.
Not a fit: Patients with bleeding or coagulation disorders, local sepsis, peripheral neuropathies, chronic pain or opioid dependency, contraindications to regional anesthesia, hypertension, or uncontrolled diabetes would not be eligible and therefore would not receive benefit from enrollment.
Why it matters
Potential benefit: If successful, this approach could reduce postoperative pain and opioid use, helping patients recover faster and potentially shorten hospital stays.
How similar studies have performed: ESPB has previously reduced 24-hour opioid consumption and improved analgesia in breast, video-assisted thoracoscopic, and cardiothoracic surgeries, though its benefit specifically for laparoscopic abdominal procedures is less established.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years. * Both sexes. * American Society of Anesthesiologists (ASA) physical status I-II. * Body mass index (BMI) between 20-30 kg/m2. * Patients undergoing laparoscopic abdominal surgeries under general anesthesia. Exclusion Criteria: * Bleeding or coagulation disorders. * Having local sepsis, pre-existing. * Peripheral neuropathies. * Chronic pain conditions. * Having any contraindication to regional anesthesia administration. * Opioid dependency. * Hypertension. * Uncontrolled diabetes mellitus.
Where this trial is running
Asyut
- Assiut University — Asyut, Egypt (Recruiting)
Study contacts
- Study coordinator: Bahaa G Saad, MD
- Email: bahaagamal@aun.edu.eg
- Phone: 00201555590977
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.